Wētā Workshop Designed TCM Cultural Experience Center Opens In Guangdong China
The Guangdong-Macao Traditional Chinese Medicine Science and Technology Industrial Park features a mix of facilities, including offices, R&D centres, hotels, retail streets, an experience centre, pharmaceutical plants, testing and extraction centres, and staff apartments.
As a core part of the park, the five-storey TCM Cultural Experience Center, with a floor area of 36,000 square metres, is the flagship of its health sector and a powerful symbol of cultural integration in the Greater Bay Area.
This new TCM Cultural Experience Center offers a fully immersive experience that brings the culture of traditional Chinese medicine to life, guiding visitors on a journey from its mythological origins to the advancements in modern practices, and on into thefuture. This natural approach to medicine is a critically important part of Chinese wellbeing, and the TCM Cultural Experience Center aims to inspire future generations to learn about this important cultural practice. Taylor, alongside creative collaborator Sam Gao, worked over seven years to realise the project in close collaboration with client Hengxin Shambala.
Wētā Workshop's Co-founder and Chief Creative Officer, Richard Taylor, says, 'For me it was critical to approach the subject with a deep sense of commitment, and to learn all that I could of the mythology, history, science, and culture of this fascinating subject.
By exploring the use of herbal medicine over centuries of Chinese wellbeing, a complex and intriguing story begins to unfold.'
The TCM Cultural Experience Center is Wētā Workshop's largest project to date, and their second large-scale immersive experience project in China, following the completion of their award-winning work on Aura: The Forest at the Edge of the Sky at the duty-free shopping mall in Haikou, on Hainan Island in 2022. The TCM Cultural Experience Center is especially significant for Taylor and the team at Wētā Workshop, not only due to the size and scale of the project, but the extent to which the team researched and designed the experience, from the uniquely designed building itself, through to the cultural narratives within its spaces.
Taylor adds, 'As I have spent close to three decades working in China, it came as an extraordinary treat to work so comprehensively on something as monumental as this experience. What started as a white board drawing in my office now stands as a magnificent structure containing an utterly unique cultural exhibition.'
'This was a very special project that is testament to the tight collaboration and creative exchange between two teams — one in New Zealand, and one in China — united by the collective endeavour of creating the world's most unique TCM Cultural Experience Center,' Taylor adds.
Wētā Workshop's head of creative media, Sam Gao, worked closely with Taylor on both creative direction and hands-on sculpting elements and says, 'Despite the challenges of often having to work remotely, the project was immensely fulfilling and brought together people from China mainland and Macau, alongside our own Workshop team in New Zealand.'
'On a more personal level, it was an honour to share my creative expertise on a project that celebrates traditional Chinese medicine and brings to life stories from my cultural upbringing,' Gao adds.
The TCM Cultural Experience Center experience starts before guests enter, with its unique building design paying homage to the herbal plants that are critical to traditional Chinese medicine. Within the building guests encounter a multitude of exhibits, including a large number of hyper-realistic up-scaled figures representing key moments from Chinese culture including Hua Tuo, Zhang Zhongjing and Li Shi Zhen.
A 50-metrre-long animated 'historical tapestry' is just one of several features which skilfully combine artistry and interactive smart tech throughout the building. The stunning central atrium showcases the story of Shen Nong with a large-scale mural on the ceiling, with 100 birds flying down towards the ground floor, connecting all five levels of the building.
Working alongside collaborator Sam Gao, Taylor and Gao strived to facilitate and connect two teams of creatives. Providing design and fabrication services from their base in Wellington, Wētā Workshop worked with New Zealand-based designers, musical composer, architects, and lighting designers to work alongside them during this unprecedented project. In collaboration with client Shambala, Taylor and Gao also art directed dozens of highly skilled Chinese creatives and technicians to complete the center.
Taylor adds, 'This project is the cumulation of a near three-decade long relationship that I have had with China, and celebrates the strong creative exchange we have established with friends and colleagues in both countries.'
The TCM Cultural Experience Center adds to Wētā Workshop's growing portfolio of immersive experiences work globally, with significant projects in New Zealand, China and the Middle East.
About Wētā Workshop
Wētā Workshop brings imaginary worlds to life by delivering concept design, physical effects, collectibles, immersive visitor experiences, creative media and digital games to the world's entertainment and creative industries. Established by Richard Taylor and Tania Rodger in 1987, they are best known for their screen work on The Lord of the Rings and Hobbit trilogies, the Avatar films, District 9 and Dune to name a few. Their work in immersive visitor experiences, such as Gallipoli: The Scale of our War, Expo 2020 Dubai's Mobility Pavilion, Aura: Forest at the Edge of the Sky and Wētā Workshop Unleashed. Based in Wellington, New Zealand, Wētā Workshop's ground-breaking work has earned them multiple international awards including five Oscars and three THEA awards. www.wetaworkshop.com
About the TCM Cultural Experience Center
The TCM Cultural Experience Center is the world's first large-scale TCM-focused experience that offers an immersive journey through an informative and visually unique experience. Designed by Richard Taylor, creative director, five-time Academy Award winner and co-founder of Wētā Workshop, the centre delivers a fantastical experience that celebrates in the culture, mythology, science and history of traditional Chinese medicine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
7 hours ago
- Scoop
MP Tama Potaka & MP Ryan Hamilton: Waikato To Become Home Of New Medical School
Hamilton will become home to New Zealand's third medical school, with Cabinet approving the business case for the new school and the establishment of a graduate-entry medical programme at the University of Waikato, MP for Hamilton West Tama Potaka and MP for Hamilton East Ryan Hamilton say. 'This is a proud day for Hamilton. Establishing a medical school here recognises our city's growing role as a centre for education, research, and healthcare delivery across the wider Waikato and beyond,' says Mr Potaka. 'This has been years in the making. I want to acknowledge the long-standing work of former Hamilton MPs Hon. David Bennett and Hon. Tim Macindoe, and MP for Taupō, Louise Upston, who have strongly championed the case for a Waikato-based medical school. It's fantastic to see that advocacy now delivering real results for our city. 'This investment will give more students from places like Hillcrest, Silverdale, and Claudelands the chance to pursue medicine close to home – while reinforcing Hamilton East as a hub for future-focused learning and health leadership,' Says Mr Hamilton. 'The school will have a strong focus on primary care and rural health, supporting the Government's priority of improving access to timely, quality healthcare across the country. 'It will deliver a more flexible pathway into medicine with a graduate-entry programme, attracting a broader range of students and building a stronger, more diverse workforce.' The Government has committed $82.85 million to the project, alongside more than $150 million in funding from the University of Waikato and philanthropic partners. Construction and planning for new teaching facilities and clinical placements will begin shortly, with the programme expected to provide 120 new doctor training places per year from 2028. The announcement builds on the Government's wider investment in the health workforce, including 100 additional medical school places being added across the University of Auckland and the University of Otago over the term of this Government, and recent expansion of nursing, pharmacy, and midwifery programmes. 'This is a major milestone for the region and a step forward in strengthening New Zealand's health system,' says Mr Potaka. 'It reflects this Government's commitment to investing in regional growth, delivering better health outcomes, and ensuring more people have the opportunity to study and train closer to home.'
Scoop
8 hours ago
- Scoop
Genetic Testing Offers Australians Insight Into MTHFR Mutations And Health Risks
Life X DNA, an Australian-based provider of genetic analysis services, is reporting continued interest in DNA-based health insights, with a particular focus on methylation and MTHFR gene mutations. The company's services include MTHFR mutation testing and broader DNA analysis, providing individuals with information about potential genetic influences on health, wellness, and disease risk. The MTHFR gene is involved in the body's methylation process, which plays a role in functions such as detoxification, cardiovascular health, and neurotransmitter production. Variations in this gene, known as MTHFR mutations, can affect how the body processes folate and homocysteine, potentially contributing to a range of health outcomes. Life X DNA's testing approach examines common MTHFR variants, as well as other genes involved in methylation pathways, offering a more comprehensive genetic profile. In addition to MTHFR-focused analysis, Life X DNA offers DNA tests in Australia that use next-generation sequencing and AI-powered software to analyse over 200 million genetic variants. The company's reports provide both summary insights and technical breakdowns, covering areas such as cardiovascular health, detoxification, mental health, and dietary needs. Test kits are available for home use, with a simple cheek swab collection method and results delivered through secure online reports. Life X DNA is 100% Australian owned and managed, with privacy controls that ensure genetic data is not sold or shared. The company's reports are designed to support conversations with healthcare professionals and include personalised recommendations for diet, lifestyle, and supplementation. This approach reflects a growing trend towards personalised healthcare and preventive strategies based on genetic information.
RNZ News
a day ago
- RNZ News
China is catching up to the US in brain tech, rivaling firms like Elon Musk's Neuralink
By Kristie Lu Stout and Fred He , CNN The chip of Beinao-1 is about the size of a coin. CNN Photo: CNN Newsource "I want to eat" popped up in Chinese characters on a computer at a public hospital in central Beijing. The words were formed from the thoughts of a 67-year-old woman with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, who is unable to speak. The demonstration, captured on video in March by Beijing Radio and Television Station, was part of a clinical trial involving five patients implanted with a coin-sized chip called Beinao-1, a wireless so-called brain computer interface (BCI) - a technology led by scientists in the US, but in which experts say China is quickly catching up. Luo Minmin, director of the Chinese Institute for Brain Research (CIBR) and the chief scientist behind the trial, said there was a "very strong" need for BCI technology, saying they had been "overwhelmed" by requests from potential patients. "The patients were saying that this feels so great, like they can gain or regain the control of (their) muscles," he told CNN in May during a rare interview at his lab, located an hour's drive away from Beijing Xuanwu Hospital, where the trial took place. Luo said the technology was showing "high accuracy" in decoding signals from the brains of patients and translating the signals into text speech or machine movements. His team is planning to speed up human trials by implanting chips into 50 to 100 more patients over the next year. "We are hoping that we can move this process faster," he said. "If it's proven to be safe and effective … it can be used clinically across the world." Luo Minmin at the Chinese Institute for Brain Research lab, in Beijingon May 28, 2025 Photo: CNN Newsource As of May, Beinao-1 says a total of five patients, the same number as Elon Musk's Neuralink , has its implants. Another US company Synchron, whose investors include Jeff Bezos and Bill Gates, has undergone trials with 10 patients, six in the United States and four in Australia. Maximilian Riesenhuber, a professor of neuroscience at Georgetown University who was not involved in the Beinao trials, told CNN that despite starting later than the US, China is making advances. "China has definitely shown the ability to not just catch up, but also then be competitive, and now actually to start, also to drive the field in some areas," he said. "Excitingly, there's a lot of research activities in both countries, because they've realized the potential in BCI." According to Precedence Research, a market research firm, the market for brain technology was worth about $2.6 billion last year and is expected to rise to $12.4 billion by 2034. But for both China and the US, this technology is about much more than cash. Chinese leader Xi Jinping has long aimed to turn his country into a science and economic powerhouse. In March, he wrote in state-owned media that the tech industry had become the "forefront" and "main battlefield" of global competition. His ambitions have sparked concern in the US, resulting in an ongoing tech war, particularly in the semiconductor industry. CIBR was jointly founded by the Beijing municipal government and several local universities in 2018, about two years after Elon Musk founded Neuralink near San Francisco. In 2023, CIBR incubated a private company named NeuCyber NeuroTech to focus on brain tech products such as Beinao-1. Luo, who is also the startup's chief scientist, gave CNN rare access to the institute in May. For years, he said, the ALS patient, who is in her 60s, was unable to express herself. "She's awake, she knows what she wants but she could not speak out," said the scientist, who got his PhD in neuroscience from the University of Pennsylvania and spent nearly a decade in the US. "Following the implantation, she can now speak simple sentences quite accurately via the system." All BCI researchers must address the balance between risk and effectiveness. Riensenhuber said most American firms use the more invasive method to place chips inside the dura mater, an outer layer of tissue that covers and protects the brain and spinal cord, in order to capture better signal. But these methods require riskier surgeries. "It is interesting to see that NeuCyber is apparently able to get enough information even through the dura to allow the decoding of specific words," he said. The test on the ALS patient, which began in March, marked the Beinao-1 chip's third trial in humans. Those trials made up what the developers described in a press release as "the world's first batch of semi-invasive implantation of wireless BCI in human brains." As of May, two more trials have been conducted, for a total of five. Amid rising geopolitical tensions, comparisons between US and Chinese tech breakthroughs are common. Brain computer interface technology first started in the 1970s in the US. Decades later, the Obama Administration launched its "Brain Initiative" in 2013, investing more than $3 billion to fund over a thousand neuroscience technology projects since, according to the National Institute of Health. Synchron, based in New York, was the first firm to start human trials in July 2021. Three years later, a new BCI system developed at UC Davis Health translated the brain signals of an ALS patient into speech, achieving an accuracy of 97% - the most accurate system of its kind, the university said in a statement. The same year, Musk's company completed its first human trial , enabling the participant to control a computer mouse with a brain implant . China got its start in brain tech only in the 1990s, but it's advancing fast. In 2014, Chinese scientists introduced the idea of a national project on brain tech to match similar efforts in the US and Europe, according to the Ministry of Science and Technology. Two years later, brain tech was mentioned in the country's five-year plan, which outlines China's national priorities and goals. "Brain science is new in China," said Lily Lin, a former research assistant at one of China's top neuroscience research units from 2021 to 2023. "So, it started a bit late, but its speed of development has been faster than other countries. And the country has given a lot of funding to many scientific research units, and this funding is increasing every year." Last year, the government issued its first ethical guidelines for research in this area. At the local level, municipal governments in Beijing, Shanghai and other major cities have also offered support for brain technology companies from research and clinical trials to commercialization. Brain models on display inside the lab of CIBR in Beijing, China on May 28, 2025. Photo: CNN Newsource Riesenhuber and other researchers from Georgetown University published research on China's BCI development in 2024, stating that efforts from Chinese researchers were "comparable in sophistication" to those in the US and the United Kingdom. "We found China's non-invasive BCI research to be comparable with that of other scientifically advanced nations and to be working to overcome obstacles to greater fidelity, throughput, and wider use," according to the issue brief. "China's invasive BCI research, while historically behind its non-invasive efforts, has picked up the pace and is approaching global standards of sophistication." Luo, who has worked in both countries, says the US is the "front-runner" in both invasive and non-invasive brain tech. But, comparing Beinao-1 and Neuralink is like looking at "apples and oranges," he added. The two systems differ not only in implant location but also in the type of brain signals recorded, as well as the method of data transmission. The Chinese chip records a wider range of brain areas, with lower precision for each neuron. "All in all, I don't think these two products are in a competitive or exclusive relationship," Luo added. "The jury is still out, and we don't know yet which route will ultimately benefit patients better." - CNN
